Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Caitlin E. Cox

January 28, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Daily News

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

L.A. McKeown

May 01, 2017

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Daily News

Los Expertos Eligen los Avances Más Importantes de 2011

Jason Kahn

March 08, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Endovascular Intervention Generally Safe in Elderly PAD Patients

June 20, 2011

News Daily News

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

January 25, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

Advertisement

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Scientific Statement Reviews Current Antithrombotic Options in PAD

July 2024 Dispatch for the CV Team

Only Half of Revascularized PAD Patients Receive GDMT

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Worse Complications After PVI in Women Highlight Research Gaps

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

TCTMD’s Top 10 Most Popular Stories for January 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

Los Expertos Eligen los Avances Más Importantes de 2011

Experts Give Their Picks for Most Important Developments of 2011

First DES for Above-the-Knee Vascular Disease on the Horizon

Endovascular Intervention Generally Safe in Elderly PAD Patients

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content